Comments

Dynavax Technologies

Q: What sector and industry does Dynavax Technologies (DVAX) operate in?

Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

DVAXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$11.50

00.00%

Pre-Market: 7:55 PM EDT

15 minutes delayed

Dynavax Technologies (DVAX) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Dynavax Technologies (NASDAQ:DVAX) Stock Quotes, Forecast and News Summary

Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	31.00 / 2.22M
Day Range	- - -
52 Wk Range	9.74 - 15.15
Market Cap	$1.51B
P/E Ratio	88.46
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	17.06%
Days to Cover	10.83

Recent News

FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients

Latest regulatory update from Dynavax on HEPLISAV-B vaccine regimen for adults on hemodialysis, with FDA's Complete Response Letter.

Vandana Singh

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.

Avi Kapoor

Cramer Suggests Buying Fast Food Chain Owner Of Popeye's, Burger King: Here's Why

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Restaurant Brands International Inc. (NYSE: QSR) is a buy.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Dynavax Technologies Corp.

Sector

Health Care

Industry

Biotechnology

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the powe...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Dynavax Technologies (DVAX) stock?

You can purchase shares of Dynavax Technologies (NASDAQ:DVAX) through any online brokerage.

View our list of the best stock brokerages

Who are Dynavax Technologies (DVAX) competitors?

Other companies in Dynavax Technologies’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Dynavax Technologies (DVAX) stock?

Dynavax Technologies has a consensus price target of $23.00.

What is the current price for Dynavax Technologies (DVAX)?

The stock price for Dynavax Technologies (NASDAQ: DVAX) is $11.5 last updated September 19, 2024 at 7:55 PM EDT.

Does Dynavax Technologies (DVAX) pay a dividend?

There are no upcoming dividends for Dynavax Technologies.

When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?

Dynavax Technologies’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Dynavax Technologies (DVAX) going to split?

There is no upcoming split for Dynavax Technologies.

What sector and industry does Dynavax Technologies (DVAX) operate in?

Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now